Global migraine treatment market is projected to register a CAGR of 12.4% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
Global Migraine Treatment Market, By Types of Migraine (Episodic, Migraine with Aura, Chronic and Others), Treatment (Acute/Abortive Treatment, Preventive/Prophylactic Treatment, Non-Pharmacological Therapies And Devices), Route of Administration (Oral, Parenteral, Nasal Sprays And Others), Product Type (Prescription and Over The Counter), Type (Branded and Generic) End User (Hospitals, Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Switzerland, Rest of Europe, Japan, China, South Korea, Australia, India, Singapore, Thailand, Malaysia, Indonesia, Vietnam, Philippines And Rest Of Asia-Pacific, Brazil, Argentina, Peru, Rest Of South America, South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel And Rest Of Middle East And Africa) Industry Trends and Forecast to 2027
Some of the major factors contributing to the growth of the global migraine treatment market are:
- Increasing prevalence of migraine
- Development of novel drugs
Market Players:
The key market players for global migraine treatment market are listed below:
- Eli Lilly and Company
- Amgen Inc
- GlaxoSmithKline plc.
- Novartis AG
- Bayer AG
- Allergan
- Abbott
- Allodynic Therapeutics, LLC
- AOBiome
- AstraZeneca
- Aurobindo Pharma USA (A Subsidiary of Aurobindo Pharma)
- Bausch Health Companies Inc
- Biohaven Pharmaceuticals
- Boehringer Ingelheim International GmbH
- Catalent, Inc
- Dr. Reddy's Laboratories Ltd
- Impel NeuroPharma, Inc
- Lundbeck
- Merck Sharp & Dohme Corp. (A Subsidiary of Merck & Co., Inc.)
- Neurelis, Inc
- Otsuka Pharmaceutical Co., Ltd. (A Subsidiary of Otsuka Holdings Co., Ltd.)
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceuticals Industries Ltd.)
- Zosano Pharma Corporation
